Cholesterol is one of the most talked about and most misunderstood markers in medicine. Most people know their number. Far fewer understand what it actually means, how it changes in the context of diet and metabolic health, or why two people with the same LDL can have completely different cardiovascular risk profiles.
This week on the Be Well by Kelly podcast I sat down with Nick Norwitz for one of the most intellectually honest and genuinely fascinating conversations I have recorded. Nick does not pretend to have all the answers. He asks better questions. And in a health landscape full of oversimplified takes and confident headlines, that is exactly the kind of voice I wanted on the show.
About Nick Norwitz
Nick Norwitz is a researcher-educator whose mission is to make metabolic health mainstream. He graduated valedictorian from Dartmouth College, majoring in Cell Biology and Biochemistry, before completing his PhD in Metabolism at the University of Oxford and his MD at Harvard Medical School.
At 21, a diagnosis of ulcerative colitis and a significant elevation in his total cholesterol propelled him into a self-directed experiment that has since spilled into global medical debate. That personal health crisis pushed Nick toward personal experimentation, deeper study, and a genuine willingness to question what the available evidence could and could not tell him. It is the lens through which he approaches everything, including this conversation.
His specialties include metabolism, lipid and cholesterol science, neuroscience, gut health, and nutrition. He is the co-founder and Chief Science Officer of NeuroVitals and one of the most compelling science communicators working today. His motto, stay curious, is not just a tagline. It is the operating principle behind everything he does.
About This Episode
I have spent years talking about blood sugar balance, protein, nutrient density, and satiety because these foundations help us feel steady in real life. But good health conversations also leave room for questions, especially when the data is more nuanced than a headline makes it seem.
That is one reason I wanted to sit down with Nick.
Nick's path into this work began with a severe ulcerative colitis health crisis that pushed him toward personal experimentation, deeper study, and a willingness to question what the evidence could and could not tell him.
We explore biomarkers, cholesterol, statins, GLP-1 medications, and peptides with that same spirit. This is a conversation for education, not a set of recommendations. We talk about what these tools can show us, where uncertainty remains, and why no single number tells the whole story of a person.
I do not rely on quick fixes because I never want a tool to crowd out nutrition, sleep, movement, and strength training. But I can see how the right support, used thoughtfully with a qualified clinician, might help someone build momentum toward lasting habits. That distinction matters to me as a practitioner and a mom.
Nick asks hard questions without pretending he has finished learning. If you want a conversation that makes complex health topics feel useful instead of frightening, I hope you will listen.
